Your browser doesn't support javascript.
Acute Worsening of Atypical Parkinson's Syndrome After Receiving Second Dose of Moderna COVID-19 Vaccine.
Russell, Rachel; Quinn, Brian.
  • Russell R; Medical College of Wisconsin, Milwaukee, Wisconsin, russellrachel25@gmail.com.
  • Quinn B; Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
WMJ ; 121(3): E46-E49, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-2084108
ABSTRACT

INTRODUCTION:

Atypical Parkinson's syndromes are a rare set of neurodegenerative conditions in which a patient experiences the typical symptoms of Parkinson's disease, in addition to various other unrelated issues. CASE PRESENTATION We present the case of a 71-year-old White man with a 1-year history of weakness and upper extremity tremors that, per patient report, rapidly worsened after receiving the second dose of the Moderna COVID-19 vaccine. His symptoms were consistent with an asymmetric atypical Parkinson's disease, with electromyogram results indicating chronic motor neuron involvement.

DISCUSSION:

There have been multiple reports of deterioration in patients with Parkinson's disease and atypical Parkinson's syndromes in response to contracting COVID-19. However, there are few, if any, case reports that describe an acute change in Parkinson-related symptoms in association with the COVID-19 vaccines.

CONCLUSIONS:

As the pandemic continues, we must continue to remain vigilant as we learn more about the long-lasting effects of the virus and vaccines.
Subject(s)
Search on Google
Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / COVID-19 Vaccines / COVID-19 Type of study: Case report / Diagnostic study / Observational study / Prognostic study / Qualitative research Topics: Long Covid / Vaccines Limits: Aged / Humans / Male Language: English Journal: WMJ Journal subject: Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / COVID-19 Vaccines / COVID-19 Type of study: Case report / Diagnostic study / Observational study / Prognostic study / Qualitative research Topics: Long Covid / Vaccines Limits: Aged / Humans / Male Language: English Journal: WMJ Journal subject: Medicine Year: 2022 Document Type: Article